Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s13277-012-0399-y.

Title:
Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer | Tumor Biology
Description:
Rsf-1 (HBXAP) was recently reported to be overexpressed in various cancers and associated with the malignant behavior of cancer cells. However, the expression of Rsf-1 and its biological roles in colon cancer have not been reported. The molecular mechanism of Rsf-1 in cancer aggressiveness remains ambiguous. In the present study, we analyzed the expression pattern of Rsf-1 in colon cancer tissues and found that Rsf-1 was overexpressed in 50.4 % of colon cancer specimens. There was a significant association between Rsf-1 overexpression and TNM stage (p = 0.0205), lymph node metastasis (p = 0.0025), and poor differentiation (p = 0.0235). Furthermore, Rsf-1 overexpression correlated with a poor prognosis in colon cancer patients (p = 0.0011). In addition, knockdown of Rsf-1 expression in HT29 and HCT116 cells with high endogenous Rsf-1 expression decrease cell proliferation and colony formation ability. Further analysis showed that Rsf-1 knockdown decreased cyclin E expression and phospho-Rb level. In conclusion, Rsf-1 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin E and phospho-Rb modulation, which makes Rsf-1 a candidate therapeutic target in colon cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We don't see any clear sign of profit-making.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {πŸ”}

cancer, article, pubmed, google, scholar, rsf, cas, colon, cell, expression, overexpression, ovarian, carcinoma, poor, amplification, central, proliferation, remodeling, gene, privacy, cookies, content, cells, access, chromatin, pathol, publish, research, search, correlates, prognosis, wang, overexpressed, survival, factor, breast, oncogene, analysis, data, information, log, journal, tumor, april, liu, dong, enhua, hbxap, cancers, patients,

Topics {βœ’οΈ}

month download article/chapter qianze dongΒ &Β enhua wang full article pdf promotes genomic instability colon cancer tissues colon cancer specimens chromatin remodeling protein high-resolution mapping privacy choices/manage cookies induces dna damage tumor-promoting functions human cancer cells oral cancer cells epithelial ovarian cancer colon cancer patients related subjects chromatin remodeling factor rsf-1 overexpression correlates article liu colon cancers postmenopausal breast cancer chromatin remodeling gene chromatin-remodeling gene malignant cell growth european economic area colony formation ability phospho-rb level phospho-rb modulation intratumoural cytogenetic heterogeneity prb-mediated repression prb-family proteins basic medical science china medical university rsf-1 overexpression correlated article log conditions privacy policy colon cancer ovarian carcinoma effusions lymph node metastasis disease-specific survival breast carcinoma effusions poor therapeutic response check access instant access accepting optional cookies promotes invasion e2f-dependent activation article cite enhua wang predicts poor survival

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer
         description: Rsf-1 (HBXAP) was recently reported to be overexpressed in various cancers and associated with the malignant behavior of cancer cells. However, the expression of Rsf-1 and its biological roles in colon cancer have not been reported. The molecular mechanism of Rsf-1 in cancer aggressiveness remains ambiguous. In the present study, we analyzed the expression pattern of Rsf-1 in colon cancer tissues and found that Rsf-1 was overexpressed in 50.4Β % of colon cancer specimens. There was a significant association between Rsf-1 overexpression and TNM stage (p = 0.0205), lymph node metastasis (p = 0.0025), and poor differentiation (p = 0.0235). Furthermore, Rsf-1 overexpression correlated with a poor prognosis in colon cancer patients (p = 0.0011). In addition, knockdown of Rsf-1 expression in HT29 and HCT116 cells with high endogenous Rsf-1 expression decrease cell proliferation and colony formation ability. Further analysis showed that Rsf-1 knockdown decreased cyclin E expression and phospho-Rb level. In conclusion, Rsf-1 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin E and phospho-Rb modulation, which makes Rsf-1 a candidate therapeutic target in colon cancer.
         datePublished:2012-04-20T00:00:00Z
         dateModified:2012-04-20T00:00:00Z
         pageStart:1485
         pageEnd:1491
         sameAs:https://doi.org/10.1007/s13277-012-0399-y
         keywords:
             Rsf-1
            Colon cancer
            Prognosis
            Proliferation
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig4_HTML.gif
         isPartOf:
            name:Tumor Biology
            issn:
               1423-0380
               1010-4283
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Shuli Liu
               affiliation:
                     name:China Medical University
                     address:
                        name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qianze Dong
               affiliation:
                     name:China Medical University
                     address:
                        name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Enhua Wang
               affiliation:
                     name:China Medical University
                     address:
                        name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer
      description: Rsf-1 (HBXAP) was recently reported to be overexpressed in various cancers and associated with the malignant behavior of cancer cells. However, the expression of Rsf-1 and its biological roles in colon cancer have not been reported. The molecular mechanism of Rsf-1 in cancer aggressiveness remains ambiguous. In the present study, we analyzed the expression pattern of Rsf-1 in colon cancer tissues and found that Rsf-1 was overexpressed in 50.4Β % of colon cancer specimens. There was a significant association between Rsf-1 overexpression and TNM stage (p = 0.0205), lymph node metastasis (p = 0.0025), and poor differentiation (p = 0.0235). Furthermore, Rsf-1 overexpression correlated with a poor prognosis in colon cancer patients (p = 0.0011). In addition, knockdown of Rsf-1 expression in HT29 and HCT116 cells with high endogenous Rsf-1 expression decrease cell proliferation and colony formation ability. Further analysis showed that Rsf-1 knockdown decreased cyclin E expression and phospho-Rb level. In conclusion, Rsf-1 is overexpressed in colon cancers and contributes to malignant cell growth by cyclin E and phospho-Rb modulation, which makes Rsf-1 a candidate therapeutic target in colon cancer.
      datePublished:2012-04-20T00:00:00Z
      dateModified:2012-04-20T00:00:00Z
      pageStart:1485
      pageEnd:1491
      sameAs:https://doi.org/10.1007/s13277-012-0399-y
      keywords:
          Rsf-1
         Colon cancer
         Prognosis
         Proliferation
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13277-012-0399-y/MediaObjects/13277_2012_399_Fig4_HTML.gif
      isPartOf:
         name:Tumor Biology
         issn:
            1423-0380
            1010-4283
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Shuli Liu
            affiliation:
                  name:China Medical University
                  address:
                     name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qianze Dong
            affiliation:
                  name:China Medical University
                  address:
                     name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Enhua Wang
            affiliation:
                  name:China Medical University
                  address:
                     name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Tumor Biology
      issn:
         1423-0380
         1010-4283
      volumeNumber:33
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:China Medical University
      address:
         name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
         type:PostalAddress
      name:China Medical University
      address:
         name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
         type:PostalAddress
      name:China Medical University
      address:
         name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Shuli Liu
      affiliation:
            name:China Medical University
            address:
               name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
               type:PostalAddress
            type:Organization
      name:Qianze Dong
      affiliation:
            name:China Medical University
            address:
               name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
               type:PostalAddress
            type:Organization
      name:Enhua Wang
      affiliation:
            name:China Medical University
            address:
               name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
      name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
      name:Department of Pathology, First Affiliated Hospital and College of Basic Medical Science, China Medical University, Shenyang, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(98)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • AOS
  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.25s.